225 related articles for article (PubMed ID: 26293643)
1. Overexpression of ubiquitin carboxyl terminal hydrolase-L1 enhances multidrug resistance and invasion/metastasis in breast cancer by activating the MAPK/Erk signaling pathway.
Wang W; Zou L; Zhou D; Zhou Z; Tang F; Xu Z; Liu X
Mol Carcinog; 2016 Sep; 55(9):1329-42. PubMed ID: 26293643
[TBL] [Abstract][Full Text] [Related]
2. UCH-L1 involved in regulating the degradation of EGFR and promoting malignant properties in drug-resistant breast cancer.
Jin Y; Zhang W; Xu J; Wang H; Zhang Z; Chu C; Liu X; Zou Q
Int J Clin Exp Pathol; 2015; 8(10):12500-8. PubMed ID: 26722437
[TBL] [Abstract][Full Text] [Related]
3. Involvement of CD147 in regulation of multidrug resistance to P-gp substrate drugs and in vitro invasion in breast cancer cells.
Li QQ; Wang WJ; Xu JD; Cao XX; Chen Q; Yang JM; Xu ZD
Cancer Sci; 2007 Jul; 98(7):1064-9. PubMed ID: 17441962
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells.
Wang WJ; Li QQ; Xu JD; Cao XX; Li HX; Tang F; Chen Q; Yang JM; Xu ZD; Liu XP
Int J Oncol; 2008 Nov; 33(5):1037-45. PubMed ID: 18949367
[TBL] [Abstract][Full Text] [Related]
5. Interaction between CD147 and P-glycoprotein and their regulation by ubiquitination in breast cancer cells.
Wang WJ; Li QQ; Xu JD; Cao XX; Li HX; Tang F; Chen Q; Yang JM; Xu ZD; Liu XP
Chemotherapy; 2008; 54(4):291-301. PubMed ID: 18689982
[TBL] [Abstract][Full Text] [Related]
6. UCH-L1 promotes invasion of breast cancer cells through activating Akt signaling pathway.
Luo Y; He J; Yang C; Orange M; Ren X; Blair N; Tan T; Yang JM; Zhu H
J Cell Biochem; 2018 Jan; 119(1):691-700. PubMed ID: 28636190
[TBL] [Abstract][Full Text] [Related]
7. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
Li C; Guan X; Xue H; Wang P; Wang M; Gai X
Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
[TBL] [Abstract][Full Text] [Related]
8. UCH-L1-containing exosomes mediate chemotherapeutic resistance transfer in breast cancer.
Ning K; Wang T; Sun X; Zhang P; Chen Y; Jin J; Hua D
J Surg Oncol; 2017 Jun; 115(8):932-940. PubMed ID: 28334432
[TBL] [Abstract][Full Text] [Related]
9. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
[TBL] [Abstract][Full Text] [Related]
10. Gain-of-function p53 mutant with 21-bp deletion confers susceptibility to multidrug resistance in MCF-7 cells.
Tsou SH; Hou MH; Hsu LC; Chen TM; Chen YH
Int J Mol Med; 2016 Jan; 37(1):233-42. PubMed ID: 26572087
[TBL] [Abstract][Full Text] [Related]
11. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.
Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z
Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231
[TBL] [Abstract][Full Text] [Related]
12. Protein arginine methyltransferase 1 may be involved in pregnane x receptor-activated overexpression of multidrug resistance 1 gene during acquired multidrug resistant.
Li T; Kong AN; Ma Z; Liu H; Liu P; Xiao Y; Jiang X; Wang L
Oncotarget; 2016 Apr; 7(15):20236-48. PubMed ID: 26934120
[TBL] [Abstract][Full Text] [Related]
13. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
[TBL] [Abstract][Full Text] [Related]
14. Rack1 Mediates the Interaction of P-Glycoprotein with Anxa2 and Regulates Migration and Invasion of Multidrug-Resistant Breast Cancer Cells.
Yang Y; Wu N; Wang Z; Zhang F; Tian R; Ji W; Ren X; Niu R
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754360
[TBL] [Abstract][Full Text] [Related]
15. Suppression of αvβ6 downregulates P-glycoprotein and sensitizes multidrug-resistant breast cancer cells to anticancer drugs.
Zhang YH; Gao ZF; Dong GH; Li X; Wu Y; Li G; Wang AL; Li HL; Yin DL
Neoplasma; 2020 Mar; 67(2):379-388. PubMed ID: 32039627
[TBL] [Abstract][Full Text] [Related]
16. Involvement of CUL4A in regulation of multidrug resistance to P-gp substrate drugs in breast cancer cells.
Wang Y; Ma G; Wang Q; Wen M; Xu Y; He X; Zhang P; Wang Y; Yang T; Zhan P; Wei G
Molecules; 2013 Dec; 19(1):159-76. PubMed ID: 24368600
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
[TBL] [Abstract][Full Text] [Related]
18. [CD147 and matrix metallo-proteinase (MMP) 2 and MMP9 expression in multidrug resistant breast cancer cells treated with P-glycoprotein substrate drugs].
Li QQ; Wang WJ; Xu GP; Cao XX; Xu JD; Chen Q; Tang F; Xu ZD
Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):247-52. PubMed ID: 17706116
[TBL] [Abstract][Full Text] [Related]
19. EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo.
Jin Y; Zhang W; Wang H; Zhang Z; Chu C; Liu X; Zou Q
Oncol Rep; 2016 Feb; 35(2):771-8. PubMed ID: 26718028
[TBL] [Abstract][Full Text] [Related]
20. FGFR4 Links Glucose Metabolism and Chemotherapy Resistance in Breast Cancer.
Xu M; Chen S; Yang W; Cheng X; Ye Y; Mao J; Wu X; Huang L; Ji J
Cell Physiol Biochem; 2018; 47(1):151-160. PubMed ID: 29763898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
